Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

NCT: NCT07322913 · RECRUITING

NCT IDNCT07322913
StatusRECRUITING
Start Date2025-12-19
Completion2026-12
SponsorIntervascular (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this registry is to evaluate the long-term safety and performance of Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy) for bypass, repair or replacement of aortic, peripheral, or carotid arteries. This registry is intended to further define the expected product lifetime of the devices and to collect data related to usefulness of the antimicrobial coatings.

Frequently Asked Questions

What is Intervascular Post-Market Clinical Follow-Up (PMCF) Registry?

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry is a clinical trial registered under NCT07322913. Current status: RECRUITING.

What is the status of NCT07322913?

The current status of NCT07322913 (Intervascular Post-Market Clinical Follow-Up (PMCF) Registry) is: RECRUITING.

When did Intervascular Post-Market Clinical Follow-Up (PMCF) Registry start?

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry started on 2025-12-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.